Max Robotics — Global Service Robot Directory + US Certification

About

Alexander Lin is a head and neck oncology researcher whose work has fundamentally shaped the treatment landscape for oropharyngeal squamous cell carcinoma (OSCC), particularly in the era of HPV-associated disease. His research centers on transoral robotic surgery (TORS), radiation de-intensification strategies, and optimizing quality of life for patients with oropharyngeal cancer. Lin's landmark 2012 prospective study evaluating TORS as a standalone treatment modality (228 citations) established critical evidence for surgical monotherapy, while his 2019 AVOID phase 2 trial (167 citations) pioneered the omission of postoperative irradiation to the primary tumor bed — a significant step toward reducing treatment-related morbidity. His body of work has also clarified risk factors for treatment failure in HPV-positive patients, patterns of locoregional recurrence, and the consequences of deviation from adjuvant therapy guidelines. Notably, Lin has explored proton therapy as a means of preserving quality of life compared to conventional photon radiation, reflecting his commitment to patient-centered outcomes. With nearly 750 cumulative citations, his contributions have meaningfully advanced efforts to de-intensify treatment without compromising oncologic control in this increasingly prevalent patient population.